John S. Weinberg - Evercore, Inc.
Management
Thank you, Ralph. Turning to market conditions, with continued low interest rates, generally high equity prices, broadly accommodative credit markets, and a growing economy and strong business confidence, all the elements remain in place for a healthy M&A environment. Focusing on transactions in the $1 billion to $10 billion range in the first nine months of 2018, global announced volume increased approximately 24% driven by an increase of 35% in announced U.S. M&A volumes and a 17% increase in European M&A volumes. Corresponding deal count increased 20% globally, driven by a 30% year-over-year increase in Europe and a 15% year-over-year increase in the United States. Overall, this is a solid environment and we continue to have active dialogues with our clients. Activism also remained elevated this year. Assets under management controlled by activist have remained high this quarter. Activity levels are strong both in the U.S. and in Europe. Equity issuance was strong in the first nine months of the year, with total volumes of $211 billion and it is expected to surpass 2017 volumes. Year-to-date, the IPO market raised $42 billion of proceeds and approximately 54% increase from the prior-year period and the highest level of IPO activity since 2014. U.S. equity trading volumes continued to decline in the first nine months of 2018. This trend, coupled with further reductions in research budgets, is resulting in commission pressure for the sell-side. Let me briefly review our Investment Banking business. The composition of advisory revenues for the quarter remained diverse and reflected contributions from multiple sectors and capabilities, including financial, healthcare, TMT, activism, and capital advisory. As is normally the case, we have reasonable visibility into the fourth quarter and our pipeline for Q1 continues to grow, however the timing of deal closings, as always, is not in our control. As Ralph mentioned, ECM experienced continued momentum, and on a latest 12 months basis, underwriting revenues were $73.4 million. While we are still active in healthcare, we are broadening our sector reach particularly in energy, real estate and transportation sectors. During the quarter, we participated in 12 transactions with 6 of 11 equity deals as a bookrunner. Notably, we completed our largest bookrun IPO to date, the $1.7 billion IPO for Elanco Animal Health. Our debt advisory and restructuring teams remain active, continuing to focus on refinancings, liability management, and debt capital advisory globally. Our recruiting efforts have been successful this year with seven senior managing directors joining us to date. We expect to announce new additions to our advisory and equities teams in the coming weeks and are in discussions with additional talented candidates who we hope will begin to build our 2019 recruiting class. We ended the quarter with 97 advisory senior managing directors. Productivity for our advisory senior managing directors continues to be market leading. Let me now turn the call to Bob to discuss our GAAP results and other financial matters.